Related Experiment Video
Updated: Dec 2, 2025
04:58
Rapid Golgi Stain for Dendritic Spine Visualization in Hippocampus and Prefrontal Cortex
Published on: December 3, 2021
7.4K
ADAP1/Centaurin-α1 Negatively Regulates Dendritic Spine Function and Memory Formation in the Hippocampus
Erzsebet M Szatmari1,2, Corey Moran3, Sarah Cohen4
1Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458 ryohei.yasuda@mpfi.org szatmarie18@ecu.edu.
Eneuro
|November 3, 2020
Summary
Centaurin-α1 (CentA1) negatively regulates dendritic spine density and plasticity in the hippocampus. Deleting CentA1 enhances spatial memory, suggesting it as a therapeutic target for cognitive decline.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Centaurin-α1 (CentA1) is an Arf6 GTPase-activating protein found in the brain.
- CentA1 is implicated in dendritic differentiation and Alzheimer's disease (AD) pathogenesis.
Purpose of the Study:
- To investigate the neurobiological functions of CentA1 signaling in the brain.
- To characterize the effects of CentA1 deletion on brain structure and function.
Main Methods:
- Development and analysis of Centa1 knock-out (KO) mice.
- Assessment of hippocampal brain development and synaptic ultrastructure.
- Evaluation of dendritic spine density and plasticity in the CA1 region.
- Testing spatial memory using the object-in-place (OIP) task.
Main Results:
- Centa1 KO mice showed no deficits in brain development or synaptic ultrastructure.
- KO mice exhibited significantly increased dendritic spine density and plasticity in the hippocampus.
- Deletion of Centa1 improved performance in the OIP spatial memory task.
Conclusions:
- CentA1 acts as a negative regulator of hippocampal spine density, plasticity, and memory formation.
- CentA1 signaling represents a potential therapeutic target for age-related memory decline and brain disorders.
Related Concept Videos
01:26Alzheimer's Disease: Overview
1.3K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.3K
01:19Role of Hippocampus in Memory
973
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
973
01:22Alzheimer's Disease: Treatment
617
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
617
01:03Long-term Depression
2.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.8K
01:05Long-term Depression
32.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.6K
01:23Role of Neurotransmitters in Memory
2.1K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.1K